Clinical Trials in Taipei, Taiwan/Taipei
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
ChemotherapyMetastatic Gastric AdenocarcinomaSecond Line
National Health Research Institutes, Taiwan45 enrolled1 locationNCT05927857
Recruiting
The Registry Study of Genetic Alterations of Melanoma in Taiwan
Primary Melanoma of the Extremity
National Health Research Institutes, Taiwan250 enrolled16 locationsNCT06952400